Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 13 | 2022 | 1637 | 1.640 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 6 | 2020 | 127 | 1.520 |
Why?
|
| Calcium | 19 | 2020 | 5756 | 1.400 |
Why?
|
| Calcium Channels, L-Type | 5 | 2015 | 240 | 1.180 |
Why?
|
| Sepsis | 6 | 2022 | 2593 | 1.170 |
Why?
|
| Endotoxemia | 3 | 2017 | 207 | 1.070 |
Why?
|
| Sodium-Calcium Exchanger | 7 | 2013 | 91 | 0.890 |
Why?
|
| Gastroparesis | 1 | 2023 | 131 | 0.770 |
Why?
|
| Myocardium | 11 | 2019 | 4776 | 0.740 |
Why?
|
| Cardiomyopathies | 3 | 2017 | 1912 | 0.720 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 3 | 2017 | 176 | 0.670 |
Why?
|
| Myocardial Contraction | 7 | 2021 | 1585 | 0.650 |
Why?
|
| Lipopolysaccharides | 4 | 2022 | 2216 | 0.610 |
Why?
|
| Sarcoplasmic Reticulum | 6 | 2017 | 158 | 0.570 |
Why?
|
| Shock, Septic | 1 | 2022 | 775 | 0.540 |
Why?
|
| Heart Diseases | 3 | 2022 | 2788 | 0.520 |
Why?
|
| Intraoperative Complications | 3 | 2011 | 1198 | 0.480 |
Why?
|
| Heart | 6 | 2017 | 4467 | 0.410 |
Why?
|
| Cardiomegaly | 1 | 2015 | 620 | 0.410 |
Why?
|
| Calcium Channels | 4 | 2019 | 622 | 0.380 |
Why?
|
| Anesthetics | 1 | 2017 | 539 | 0.380 |
Why?
|
| Reactive Oxygen Species | 3 | 2022 | 2077 | 0.360 |
Why?
|
| Sarcomeres | 3 | 2019 | 374 | 0.350 |
Why?
|
| Anesthesia | 3 | 2023 | 1561 | 0.340 |
Why?
|
| Mitochondria, Heart | 2 | 2021 | 247 | 0.340 |
Why?
|
| Guanylate Cyclase | 3 | 2016 | 201 | 0.320 |
Why?
|
| Anabolic Agents | 1 | 2010 | 247 | 0.310 |
Why?
|
| Up-Regulation | 1 | 2017 | 4217 | 0.310 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2021 | 2073 | 0.300 |
Why?
|
| Nickel | 4 | 2000 | 130 | 0.300 |
Why?
|
| Atrioventricular Block | 1 | 2008 | 120 | 0.290 |
Why?
|
| Infarction | 1 | 2008 | 244 | 0.290 |
Why?
|
| Trachea | 1 | 2012 | 1076 | 0.290 |
Why?
|
| Coloring Agents | 1 | 2008 | 566 | 0.270 |
Why?
|
| Cyclic AMP | 3 | 2000 | 1472 | 0.260 |
Why?
|
| Membrane Potentials | 5 | 2004 | 1137 | 0.260 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 1990 | 0.260 |
Why?
|
| Cytokines | 2 | 2022 | 7322 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 11725 | 0.250 |
Why?
|
| Thiourea | 1 | 2004 | 63 | 0.240 |
Why?
|
| Androgens | 1 | 2010 | 1281 | 0.220 |
Why?
|
| Calcium Channel Blockers | 4 | 2000 | 690 | 0.220 |
Why?
|
| Heart Rate | 2 | 2011 | 4091 | 0.220 |
Why?
|
| Cadmium | 3 | 1999 | 212 | 0.210 |
Why?
|
| Glucagon-Like Peptides | 1 | 2023 | 127 | 0.210 |
Why?
|
| Calcium Signaling | 2 | 2020 | 721 | 0.210 |
Why?
|
| Cardiotonic Agents | 1 | 2004 | 535 | 0.190 |
Why?
|
| Animals | 23 | 2022 | 168757 | 0.190 |
Why?
|
| Peptides | 4 | 2004 | 4409 | 0.190 |
Why?
|
| Electrocardiography | 2 | 2011 | 6442 | 0.190 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2021 | 96 | 0.180 |
Why?
|
| Sarcolemma | 1 | 1999 | 66 | 0.180 |
Why?
|
| Spinal Cord | 1 | 2008 | 1809 | 0.180 |
Why?
|
| Sodium | 4 | 2004 | 1623 | 0.180 |
Why?
|
| Cyclooxygenase 1 | 1 | 2019 | 104 | 0.170 |
Why?
|
| Catalase | 1 | 2019 | 222 | 0.170 |
Why?
|
| Cecum | 1 | 2019 | 237 | 0.160 |
Why?
|
| Ligation | 1 | 2019 | 453 | 0.160 |
Why?
|
| Ion Transport | 3 | 2004 | 320 | 0.160 |
Why?
|
| Punctures | 1 | 2019 | 374 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 21827 | 0.150 |
Why?
|
| Action Potentials | 3 | 2003 | 1806 | 0.140 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 611 | 0.140 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2023 | 868 | 0.140 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2021 | 859 | 0.140 |
Why?
|
| Heart Failure | 5 | 2020 | 10900 | 0.140 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 2025 | 0.140 |
Why?
|
| Models, Animal | 1 | 2022 | 2171 | 0.130 |
Why?
|
| Guinea Pigs | 5 | 2003 | 1386 | 0.130 |
Why?
|
| Mice | 8 | 2022 | 81183 | 0.130 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 1997 | 494 | 0.130 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 1116 | 0.130 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2011 | 1240 | 0.120 |
Why?
|
| Dogs | 4 | 2004 | 3912 | 0.120 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2004 | 845 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2022 | 2499 | 0.120 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 18029 | 0.120 |
Why?
|
| Cells, Cultured | 7 | 2020 | 19229 | 0.110 |
Why?
|
| Oxidative Stress | 2 | 2021 | 3086 | 0.110 |
Why?
|
| Male | 17 | 2022 | 350118 | 0.110 |
Why?
|
| Heart Ventricles | 4 | 2003 | 3821 | 0.100 |
Why?
|
| Cyclic GMP | 1 | 2013 | 409 | 0.100 |
Why?
|
| Tracheal Neoplasms | 1 | 2012 | 124 | 0.100 |
Why?
|
| Weight Loss | 1 | 2023 | 2622 | 0.100 |
Why?
|
| Rabbits | 4 | 1999 | 4894 | 0.100 |
Why?
|
| Tracheal Stenosis | 1 | 2012 | 226 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2021 | 2899 | 0.090 |
Why?
|
| Bradycardia | 1 | 2011 | 307 | 0.090 |
Why?
|
| Ion Channel Gating | 2 | 2004 | 437 | 0.080 |
Why?
|
| Intraoperative Care | 1 | 2012 | 767 | 0.080 |
Why?
|
| Ephedrine | 1 | 2008 | 54 | 0.080 |
Why?
|
| Cysteine | 1 | 2013 | 874 | 0.080 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2008 | 57 | 0.080 |
Why?
|
| Adrenergic Agents | 1 | 2008 | 70 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 1081 | 0.080 |
Why?
|
| Cystoscopy | 1 | 2008 | 134 | 0.080 |
Why?
|
| Metoprolol | 1 | 2008 | 93 | 0.080 |
Why?
|
| Propanolamines | 1 | 2008 | 167 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2020 | 8301 | 0.080 |
Why?
|
| Caffeine | 2 | 2004 | 699 | 0.080 |
Why?
|
| Muscarinic Antagonists | 1 | 2008 | 137 | 0.080 |
Why?
|
| Airway Obstruction | 1 | 2012 | 664 | 0.080 |
Why?
|
| Midazolam | 1 | 2008 | 270 | 0.070 |
Why?
|
| Electric Conductivity | 2 | 1997 | 411 | 0.070 |
Why?
|
| Paralysis | 1 | 2008 | 247 | 0.070 |
Why?
|
| Patch-Clamp Techniques | 2 | 1999 | 964 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2012 | 1486 | 0.070 |
Why?
|
| Echocardiography | 2 | 2016 | 5102 | 0.070 |
Why?
|
| Blood Pressure | 3 | 2011 | 8554 | 0.070 |
Why?
|
| Anesthetics, Intravenous | 1 | 2008 | 417 | 0.060 |
Why?
|
| Hypotension | 1 | 2011 | 884 | 0.060 |
Why?
|
| Electric Stimulation | 2 | 2000 | 1767 | 0.060 |
Why?
|
| Monitoring, Intraoperative | 1 | 2011 | 957 | 0.060 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2004 | 123 | 0.060 |
Why?
|
| Phenyl Ethers | 1 | 2004 | 58 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2012 | 1364 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2009 | 871 | 0.060 |
Why?
|
| Apoptosis | 1 | 2020 | 9727 | 0.060 |
Why?
|
| Shock, Cardiogenic | 1 | 2009 | 688 | 0.060 |
Why?
|
| Exercise Test | 1 | 2011 | 2074 | 0.060 |
Why?
|
| Preoperative Care | 1 | 2012 | 2250 | 0.060 |
Why?
|
| Ventricular Remodeling | 2 | 2021 | 1224 | 0.060 |
Why?
|
| Female | 7 | 2022 | 380194 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2008 | 1850 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2020 | 1866 | 0.050 |
Why?
|
| Humans | 16 | 2023 | 744343 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2019 | 7880 | 0.050 |
Why?
|
| Propofol | 1 | 2008 | 629 | 0.050 |
Why?
|
| Tachycardia | 1 | 2004 | 619 | 0.050 |
Why?
|
| Ventricular Fibrillation | 1 | 2004 | 538 | 0.050 |
Why?
|
| Ventricular Function | 1 | 2003 | 416 | 0.050 |
Why?
|
| Buffers | 1 | 2000 | 147 | 0.050 |
Why?
|
| Thapsigargin | 1 | 2000 | 104 | 0.050 |
Why?
|
| Electrophysiology | 2 | 2001 | 1308 | 0.050 |
Why?
|
| Oxidants | 1 | 2020 | 164 | 0.050 |
Why?
|
| Postoperative Complications | 2 | 2012 | 15295 | 0.040 |
Why?
|
| Prostatectomy | 1 | 2008 | 1890 | 0.040 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2000 | 215 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 2011 | 1876 | 0.040 |
Why?
|
| Aniline Compounds | 1 | 2004 | 986 | 0.040 |
Why?
|
| Dietary Sucrose | 1 | 2021 | 246 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 916 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2004 | 1375 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2004 | 1189 | 0.040 |
Why?
|
| Ventricular Function, Left | 2 | 2021 | 3670 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14557 | 0.040 |
Why?
|
| Nitric Oxide | 2 | 2009 | 2132 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2020 | 731 | 0.040 |
Why?
|
| Biological Transport | 2 | 1997 | 2118 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1997 | 689 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2011 | 57776 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 2187 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2011 | 63114 | 0.030 |
Why?
|
| Kinetics | 1 | 2000 | 6473 | 0.030 |
Why?
|
| Rats | 2 | 1999 | 24260 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 13815 | 0.030 |
Why?
|
| Cell Membrane | 2 | 1999 | 3748 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 18111 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2023 | 2872 | 0.020 |
Why?
|
| Time Factors | 3 | 2010 | 40075 | 0.020 |
Why?
|
| Lipoproteins | 1 | 1996 | 878 | 0.020 |
Why?
|
| Models, Biological | 2 | 2004 | 9583 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 11727 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 1997 | 1917 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 39050 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 3798 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2009 | 199 | 0.020 |
Why?
|
| Lupus Vulgaris | 1 | 1968 | 9 | 0.020 |
Why?
|
| Aged | 4 | 2011 | 163280 | 0.020 |
Why?
|
| Tuberculosis, Cutaneous | 1 | 1968 | 17 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1999 | 10943 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1997 | 2268 | 0.020 |
Why?
|
| Middle Aged | 4 | 2011 | 213383 | 0.020 |
Why?
|
| Endotoxins | 1 | 2009 | 527 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 1213 | 0.020 |
Why?
|
| Research Design | 1 | 1999 | 5987 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 85781 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2009 | 3701 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 12072 | 0.010 |
Why?
|
| Caveolin 3 | 1 | 2002 | 25 | 0.010 |
Why?
|
| Risk Factors | 2 | 2008 | 72290 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2011 | 77449 | 0.010 |
Why?
|
| Herpes Zoster | 1 | 1965 | 264 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2002 | 51 | 0.010 |
Why?
|
| Caveolins | 1 | 2002 | 104 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2002 | 399 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2002 | 170 | 0.010 |
Why?
|
| Encephalitis | 1 | 1965 | 423 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1996 | 6077 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2002 | 346 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 534 | 0.010 |
Why?
|
| Adult | 4 | 2011 | 214055 | 0.010 |
Why?
|
| Dialysis Solutions | 1 | 1999 | 39 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2002 | 689 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6538 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 4420 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2002 | 1726 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 2373 | 0.010 |
Why?
|
| Mutation | 1 | 2020 | 29786 | 0.010 |
Why?
|
| Gap Junctions | 1 | 1997 | 233 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 6171 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1997 | 2557 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 1996 | 977 | 0.010 |
Why?
|
| Fasting | 1 | 1996 | 1593 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 9734 | 0.010 |
Why?
|
| Epilepsy | 1 | 1965 | 3310 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1996 | 2035 | 0.000 |
Why?
|
| Cholesterol | 1 | 1996 | 2917 | 0.000 |
Why?
|
| Linear Models | 1 | 1996 | 5952 | 0.000 |
Why?
|
| Carrier Proteins | 1 | 1997 | 5021 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2002 | 23403 | 0.000 |
Why?
|
Concepts
(211)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_